In addition, co-localization of CYP1A1 and cytokeratin 8/18 expression in alveoli allowed detection of CYP1A1 expression in intact AT-II cells within the lung [3,4], and demonstrated decreased PAH-induced CYP1A1 in AT-II cells. The gene discussed is CYP1A1; the disease is pulmonary arterial hypertension.